Acorda Recognized by National Organization for Rare Disorders for Contribution to Treatment of MS

News   May 19, 2010

 
Acorda Recognized by National Organization for Rare Disorders for Contribution to Treatment of MS
 
 
 

RELATED ARTICLES

Symmetry-breaking Method Opens Way for Bioactive Compounds

News

EPFL chemists have developed a new catalytic method for symmetry breaking. Published in Angewandte Chemie, the method can help synthesize important building blocks for bioactive compounds such as anticancer drugs.

READ MORE

HIV Saliva Test Adapted for Rapid Zika Diagnosis

News

Researchers are developing a novel test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current commercial tests.

READ MORE

‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug Treatment

News

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tell in advance which treatments will work, a major new study reports.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE